Current Nationwide Landscape of Cardiac Surgery for Children With Trisomy 18 in Japan

Shintaro Nemoto1, Hisateru Tachimori2,3, Tomoki Kosho4,5

  • 1Department of Thoracic and Cardiovascular Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.

Insights

Cardiac surgery for children with trisomy 18 is increasing in Japan. This study analyzed nationwide data, finding 8.4% in-hospital mortality, highlighting the need for better consensus on surgical care for these vulnerable patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Genetic Syndromes

Background:

  • Cardiac surgery for trisomy 18 remains controversial in Japan.
  • Retrospective studies show varying success rates.
  • Lack of consensus hinders optimal patient care.

Purpose of the Study:

  • To establish a benchmark for cardiac surgery in children with trisomy 18 using nationwide data.
  • To inform consensus-building among Japanese healthcare providers.
  • To identify factors influencing surgical outcomes in this population.

Main Methods:

  • Analysis of the Japan Cardiovascular Surgery Database (2013-2021).
  • Inclusion of cardiothoracic surgeries in children with congenital heart disease.
  • Focus on cases involving trisomy 18.

Main Results:

  • 789 surgeries for 502 children with trisomy 18 (1.0% of total).
  • High rates of simple/closed-heart procedures (96.1%/76.0%).
  • Significant postoperative complications (35.3% noncardiac, 30.5% cardiac), with 8.4% in-hospital mortality.

Conclusions:

  • Nationwide data provides a benchmark for trisomy 18 cardiac surgery.
  • Noncardiac and cardiac complications, along with infections, are significant concerns.
  • Further research is needed to optimize surgical strategies for vulnerable children with trisomy 18.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926